Investigational Product Accountability in Clinical Trials
Investigational Product Accountability in Clinical Trials Ensuring Investigational Product Accountability in Clinical Trials Introduction: Why IMP Accountability is Critical Investigational Product (IMP) accountability ensures that every vial, tablet, or kit dispensed in a clinical trial is tracked from manufacture to destruction. For US pharmaceutical sponsors, the FDA expects complete documentation of IMP handling as a…
Read More “Investigational Product Accountability in Clinical Trials” »